166 related articles for article (PubMed ID: 32599335)
1. Recruitment of properdin by bi-specific nanobodies activates the alternative pathway of complement.
Pedersen DV; Rösner T; Hansen AG; Andersen KR; Thiel S; Andersen GR; Valerius T; Laursen NS
Mol Immunol; 2020 Aug; 124():200-210. PubMed ID: 32599335
[TBL] [Abstract][Full Text] [Related]
2. Activation of the alternative pathway of human complement by autologous cells expressing transmembrane recombinant properdin.
Vuagnat BB; Mach J; Le Doussal JM
Mol Immunol; 2000 Jun; 37(8):467-78. PubMed ID: 11090881
[TBL] [Abstract][Full Text] [Related]
3. Properdin and complement activation: a fresh perspective.
Hourcade DE
Curr Drug Targets; 2008 Feb; 9(2):158-64. PubMed ID: 18288967
[TBL] [Abstract][Full Text] [Related]
4. Identification of a novel mode of complement activation on stimulated platelets mediated by properdin and C3(H2O).
Saggu G; Cortes C; Emch HN; Ramirez G; Worth RG; Ferreira VP
J Immunol; 2013 Jun; 190(12):6457-67. PubMed ID: 23677468
[TBL] [Abstract][Full Text] [Related]
5. Structural basis for the stabilization of the complement alternative pathway C3 convertase by properdin.
Alcorlo M; Tortajada A; Rodríguez de Córdoba S; Llorca O
Proc Natl Acad Sci U S A; 2013 Aug; 110(33):13504-9. PubMed ID: 23901101
[TBL] [Abstract][Full Text] [Related]
6. Linkage specificity and role of properdin in activation of the alternative complement pathway by fungal glycans.
Agarwal S; Specht CA; Haibin H; Ostroff GR; Ram S; Rice PA; Levitz SM
mBio; 2011; 2(5):. PubMed ID: 21878570
[TBL] [Abstract][Full Text] [Related]
7. The properdin pathway: an "alternative activation pathway" or a "critical amplification loop" for C3 and C5 activation?
Harrison RA
Semin Immunopathol; 2018 Jan; 40(1):15-35. PubMed ID: 29167939
[TBL] [Abstract][Full Text] [Related]
8. Properdin binds to late apoptotic and necrotic cells independently of C3b and regulates alternative pathway complement activation.
Xu W; Berger SP; Trouw LA; de Boer HC; Schlagwein N; Mutsaers C; Daha MR; van Kooten C
J Immunol; 2008 Jun; 180(11):7613-21. PubMed ID: 18490764
[TBL] [Abstract][Full Text] [Related]
9. Initiation of the alternative pathway of complement: recognition of activators by bound C3b and assembly of the entire pathway from six isolated proteins.
Schreiber RD; Pangburn MK; Lesavre PH; Müller-Eberhard HJ
Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3948-52. PubMed ID: 279011
[TBL] [Abstract][Full Text] [Related]
10. Soluble collectin-12 mediates C3-independent docking of properdin that activates the alternative pathway of complement.
Zhang J; Song L; Pedersen DV; Li A; Lambris JD; Andersen GR; Mollnes TE; Ma YJ; Garred P
Elife; 2020 Sep; 9():. PubMed ID: 32909942
[TBL] [Abstract][Full Text] [Related]
11. The role of C1s, C1r and properdin in the initiation of the C3b-dependent feedback mechanism of the complement system.
Johnson U
Acta Pathol Microbiol Scand C; 1978 Apr; 86(2):73-8. PubMed ID: 696332
[TBL] [Abstract][Full Text] [Related]
12. Functional and structural insight into properdin control of complement alternative pathway amplification.
Pedersen DV; Roumenina L; Jensen RK; Gadeberg TA; Marinozzi C; Picard C; Rybkine T; Thiel S; Sørensen UB; Stover C; Fremeaux-Bacchi V; Andersen GR
EMBO J; 2017 Apr; 36(8):1084-1099. PubMed ID: 28264884
[TBL] [Abstract][Full Text] [Related]
13. Alternative pathway of complement: recruitment of precursor properdin by the labile C3/C5 convertase and the potentiation of the pathway.
Medicus RG; Götze O; Müller-Eberhard HJ
J Exp Med; 1976 Oct; 144(4):1076-93. PubMed ID: 978134
[TBL] [Abstract][Full Text] [Related]
14. Structural studies offer a framework for understanding the role of properdin in the alternative pathway and beyond.
Pedersen DV; Lorentzen J; Andersen GR
Immunol Rev; 2023 Jan; 313(1):46-59. PubMed ID: 36097870
[TBL] [Abstract][Full Text] [Related]
15. Properdin binds independent of complement activation in an in vivo model of anti-glomerular basement membrane disease.
O'Flynn J; Kotimaa J; Faber-Krol R; Koekkoek K; Klar-Mohamad N; Koudijs A; Schwaeble WJ; Stover C; Daha MR; van Kooten C
Kidney Int; 2018 Dec; 94(6):1141-1150. PubMed ID: 30322716
[TBL] [Abstract][Full Text] [Related]
16. A novel antibody against human properdin inhibits the alternative complement system and specifically detects properdin from blood samples.
Pauly D; Nagel BM; Reinders J; Killian T; Wulf M; Ackermann S; Ehrenstein B; Zipfel PF; Skerka C; Weber BH
PLoS One; 2014; 9(5):e96371. PubMed ID: 24797388
[TBL] [Abstract][Full Text] [Related]
17. Properdin: A multifaceted molecule involved in inflammation and diseases.
Chen JY; Cortes C; Ferreira VP
Mol Immunol; 2018 Oct; 102():58-72. PubMed ID: 29954621
[TBL] [Abstract][Full Text] [Related]
18. CR2 is a complement activator and the covalent binding site for C3 during alternative pathway activation by Raji cells.
Mold C; Nemerow GR; Bradt BM; Cooper NR
J Immunol; 1988 Mar; 140(6):1923-9. PubMed ID: 2831273
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the interactions between properdin, the third component of complement (C3), and its physiological activation products.
Farries TC; Lachmann PJ; Harrison RA
Biochem J; 1988 May; 252(1):47-54. PubMed ID: 3421908
[TBL] [Abstract][Full Text] [Related]
20. Properdin can initiate complement activation by binding specific target surfaces and providing a platform for de novo convertase assembly.
Spitzer D; Mitchell LM; Atkinson JP; Hourcade DE
J Immunol; 2007 Aug; 179(4):2600-8. PubMed ID: 17675523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]